Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine Fluarix in Adolescents Previously Vaccinated With GSK Biologicals' H1N1 Vaccine PandemrixTM.
Phase of Trial: Phase IV
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Influenza virus vaccine (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 15 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 25 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.